Cargando…

Comorbidities in unclassifiable interstitial lung disease

BACKGROUND: Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. We aimed to describe the prevalence of comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prior, Thomas Skovhus, Hyldgaard, Charlotte, Torrisi, Sebastiano Emanuele, Kronborg-White, Sissel, Ganter, Claudia, Bendstrup, Elisabeth, Kreuter, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925215/ https://www.ncbi.nlm.nih.gov/pubmed/35296320 http://dx.doi.org/10.1186/s12931-022-01981-3

Ejemplares similares

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial
por: Kronborg-White, Sissel, et al.
Publicado: (2020)

Hypersensitivity pneumonitis among wind musicians – an overlooked disease?
por: Møller, Janne, et al.
Publicado: (2017)

Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation
por: Peshbahar, Soran, et al.
Publicado: (2022)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2019)

Introduction of cryobiopsies in the diagnostics of interstitial lung diseases – experiences in a referral center
por: Kronborg-White, Sissel, et al.
Publicado: (2017)

Surgical Lung Biopsy and Cryobiopsy in Fibrosing Interstitial Lung Diseases: One Swallow Does Not Make a Summer
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data
por: Knarborg, Malene, et al.
Publicado: (2023)

Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort
por: Hyldgaard, Charlotte, et al.
Publicado: (2021)

Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy—experiences based on 250 biopsy procedures
por: Kronborg-White, Sissel, et al.
Publicado: (2021)

Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
por: Jensen, Mads Lynge, et al.
Publicado: (2019)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma
por: Leung, Stefanie C, et al.
Publicado: (2015)

Unclassifiable interstitial lung disease: a pathologist's perspective
por: Jones, Kirk D.
Publicado: (2018)

Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study
por: Knarborg, Malene, et al.
Publicado: (2022)

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
por: Kronborg-White, Sissel, et al.
Publicado: (2021)

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
por: Kreuter, Michael, et al.
Publicado: (2021)

Pulmonary Alveolar Microlithiasis – A Review
por: Enemark, Asbjørn, et al.
Publicado: (2021)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates
por: Hoyer, Nils, et al.
Publicado: (2022)

Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis
por: Molina-Molina, Maria, et al.
Publicado: (2022)

Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias
por: Traila, Daniel, et al.
Publicado: (2017)

Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis
por: Kronborg-White, Sissel, et al.
Publicado: (2018)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
por: Ryerson, Christopher J., et al.
Publicado: (2021)

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
por: Hoyer, Nils, et al.
Publicado: (2019)

Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment
por: Kølner-Augustson, Line, et al.
Publicado: (2020)

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
por: Maher, Toby M, et al.
Publicado: (2018)

Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi
por: MORITA, Tomoya, et al.
Publicado: (2018)

Two Series of Familial Cases With Unclassified Interstitial Pneumonia With Fibrosis
por: Lee, Eun, et al.
Publicado: (2012)

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2020)

No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis
por: Bendstrup, Elisabeth, et al.
Publicado: (2014)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Emphysema mimicking interstitial lung disease: Two case reports
por: Juhl, Kasper S., et al.
Publicado: (2014)

Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis
por: Schwarzkopf, Larissa, et al.
Publicado: (2018)

Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study
por: Man, Milena Adina, et al.
Publicado: (2023)

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
por: Dupin, Clairelyne, et al.
Publicado: (2020)

Remarkable benefits of intravenous immunoglobulin (IVIG) in a patient with polymyositis-associated acute interstitial lung disease
por: Peshbahar, Soran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bv0to4jeqmdhjv5g5vu6qr8l6